Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 127 for “"nanomedicine"”.

  1. Development of an inhalable nanomedicine for lung cancer

    Lung cancer affects over 2 million people worldwide and became the major cause of death in cancer patients (18.4%) in 2018. The treatment of non-small cell lung cancer (NSCLC), accounting for 85% of total lung cancer, involves chemotherapy, radiotherapy, and surgery. However, such a therapeutic …

    qu-belfast Repository record for Development of an inhalable nanomedicine for lung cancer (opens in a new tab)

  2. Sviluppo di nanomedicine per la somministrazione oculare di farmaci

    … maggiori. I recenti progressi nel campo delle nanomedicine hanno contribuito a migliorare la somministrazione di farmaci nel segmento oculare posteriore. I nanosistemi hanno fornito molteplici vantaggi, tra cui la capacità di migliorare la somministrazione di farmaci scarsamente solubili e di …

    catania Repository record for Sviluppo di nanomedicine per la somministrazione oculare di farmaci (opens in a new tab)

  3. Development of Nanomedicine to Simultaneously Target Pancreatic Cancer Cells and Stroma

    Dense desmoplastic stroma is a fundamental characteristic of pancreatic ductal adenocarcinoma (PDAC) and comprises up to 80% of the tumor mass, which acts as a barrier that impedes the delivery of antitumor drugs into the tumor microenvironment and reduces the therapeutic efficacy. The objective of …

    umkc Repository record for Development of Nanomedicine to Simultaneously Target Pancreatic Cancer Cells and Stroma (opens in a new tab)

  4. Fighting cancer with nanomedicine−drug-polyester nanoconjugates for targeted cancer therapy

    The aim of my Ph. D. research is to develop drug-polyester nanoconjugates (NCs) as a novel translational polymeric drug delivery system that can successfully evade non-specific uptake by reticuloendothelial system (RES) and facilitate targeted cancer diagnosis and therapy. By uniquely integrating …

    uiuc Repository record for Fighting cancer with nanomedicine−drug-polyester nanoconjugates for targeted cancer therapy (opens in a new tab)

  5. Optimizing Emerging Healthcare Innovations in 3D Printing, Nanomedicine, and Imageable Biomaterials

    … efforts in these fields. First, in the realm of nanomedicine, we discuss the optimization and characterization of sodium thiosulfate facilitated gold nanoparticle synthesis. While many nanoparticles have been examined as agents for photothermal cancer therapy, we closely examine the structure and …

    vt Repository record for Optimizing Emerging Healthcare Innovations in 3D Printing, Nanomedicine, and Imageable Biomaterials (opens in a new tab)

  6. Design, Development and Evaluation of Dual Drug Nanomedicine for Non-Small Cell Lung Cancer

    <p>Resistance to conventional chemotherapy is a big challenge in the treatment of cancer including non-small cell lung cancer (NSCLC). A combination of natural chemo sensitizer agents with chemotherapy offers unique advantages over monotherapy alone. However, free unbound drugs, (in combination or …

    tenn-hsc Repository record for Design, Development and Evaluation of Dual Drug Nanomedicine for Non-Small Cell Lung Cancer (opens in a new tab)

  7. The impact of hypoxia on nanomedicine uptake and efflux in human breast cancer cells

    … to undermine the therapeutic efficacy of nanomedicines designed for endocytic uptake and specific intracellular trafficking (Chapter 1). The aim of this thesis was to examine the impact of hypoxia and simulated reperfusion on the in vitro uptake and release of nanomedicines by human breast …

    strathclyde Repository record for The impact of hypoxia on nanomedicine uptake and efflux in human breast cancer cells (opens in a new tab)

  8. Tackling the Bottlenecks in Translational Nanomedicine: Towards Precision in Size Control and Facile Nanoformulation

    Nanomedicine has been an intensive research area for decades. Despite the immense research output, the translation of nanoparticle-based formulations into clinics has been limited. The efficient clinical translation of nanomedicine is impeded by several bottlenecks that include low targeting …

    cambridge Repository record for Tackling the Bottlenecks in Translational Nanomedicine: Towards Precision in Size Control and Facile Nanoformulation (opens in a new tab)

  9. RNA Interference for Improving the Outcome of Islet Transplantation and Polymeric Micelle‑based Nanomedicine for Cancer Therapy

    <p>Ex vivo gene transfer has been used to improve the outcome of islet transplantation for treating type I diabetes. RNA interference is an effective approach for reducing gene expressions at the mRNA level. The application of RNA interference to improve the outcome of islet transplantation was …

    tenn-hsc Repository record for RNA Interference for Improving the Outcome of Islet Transplantation and Polymeric Micelle‑based Nanomedicine for Cancer Therapy (opens in a new tab)

  10. Innovative formulations for the treatment of Plasmodium infections

    Nanomedicine is one of the most innovative strategies to target drugs at the action site and increase their activity index. Phytomedicine is the most traditional method used to treat human diseases and solve health problems. Their combination represents the future prospective to a better care of …

    cagliari Repository record for Innovative formulations for the treatment of Plasmodium infections (opens in a new tab)

  11. Precisely size controlled drug-silica nanoconjugate for cancer therapy

    … and to identify the optimal size of nanomedicine for the highest anticancer efficacy. I developed a novel drug delivery platform based on drug-silica nanoconjugates (drug-NCs) that can be controllably fabricated with nearly any desired sizes between 20 and 200 nm, with extremely …

    uiuc Repository record for Precisely size controlled drug-silica nanoconjugate for cancer therapy (opens in a new tab)

  12. Defining Delivery Pathways of Nanoparticles

    The goal of nanomedicine is to use nanoparticles to carry drugs to specific target site in the body. For cancer nanomedicine, a recent meta-analysis showed that only 0.7% of the injected nanoparticles reach the tumour. To address this delivery inefficiency, it is important to examine each …

    toronto-retro Repository record for Defining Delivery Pathways of Nanoparticles (opens in a new tab)

  13. The Molecular and Cellular Mechanisms for Nanoparticle Transport

    The goal of cancer nanomedicine is to deliver drugs to the tumour using nanoparticles. However, this tumour delivery is not an efficient process. Less than 1% of nanoparticles injected into the blood will reach the tumour while the rest of nanoparticles accumulate in off-target tissues. To improve …

    toronto-retro Repository record for The Molecular and Cellular Mechanisms for Nanoparticle Transport (opens in a new tab)

  14. Dual Receptor Uptake of Low-Density Lipoprotein Docosahexaenoic Acid (LDL-DHA) Elicits Differential Sensitivity Across Breast Cancer Subtypes

    We proposed to treat breast cancer with a novel nanomedicine previously shown to be effective in the treatment of primary liver tumors in rats. This nanoparticle is comprised of the low-density lipoprotein which acts as a carrier for the omega-3 fatty acid docosahexaenoic acid (DHA). The LDL-DHA …

    utswmed Repository record for Dual Receptor Uptake of Low-Density Lipoprotein Docosahexaenoic Acid (LDL-DHA) Elicits Differential Sensitivity Across Breast Cancer Subtypes (opens in a new tab)

  15. A drug-free theranostic approach for localized and systemic diseases via nanoparticles

    The emergence of field of nanomedicine for addressing the biomedical challenges created a toolkit which has been evolving dynamically with the advances in the medicine itself. At the heart of nanomedicine, nanoparticles exist which are envisioned to shift the paradigm of conventional therapy by …

    uiuc Repository record for A drug-free theranostic approach for localized and systemic diseases via nanoparticles (opens in a new tab)

  16. Design strategies and application of stimuli-responsive nanoparticles for cancer diagnosis and therapy

    … and investment have been given in cancer nanomedicine with the hope to reduce drug-associated toxicity by targeting cancer cells in a heterogeneous tumor environment. Nanomedicine is the drug-containing nanostructured construct with a large surface-to-volume ratio, which has plenty of room …

    ksu Repository record for Design strategies and application of stimuli-responsive nanoparticles for cancer diagnosis and therapy (opens in a new tab)

  17. EGFR-Targeted Polymeric Micelles For Targeted Pc 4-PDT Of Oropharyngeal Tumors

    … research objective is to develop an effective nanomedicine platform for targeted delivery of the photosensitizer drug Pc 4 to sites of head and neck cancer to enhance the clinical repertoire of Pc 4-induced photodynamic therapy (PDT) in these malignancies. The specific aims are to: (1) …

    ohiolink Repository record for EGFR-Targeted Polymeric Micelles For Targeted Pc 4-PDT Of Oropharyngeal Tumors (opens in a new tab)

  18. Trigger-responsive nanomedicines through controlled chemistry

    … mark a milestone in the formulation of nanomedicine and will have significant impact on nanomedicine platform design as well as their clinical translation. In connection with the dimeric prodrug design, a trigger-responsive amphiphilic polymeric nano-assembly is also explored for cancer …

    uiuc Repository record for Trigger-responsive nanomedicines through controlled chemistry (opens in a new tab)

Page 1 of 7